We have used prostate cancer cell lines and stromal-conditioned media to study the regulatory interplay between prostate epithelial and stromal cells during prostate cancer progression, and have now begun to tease apart the relationships between stromally-derived HGF signal, Met signal reception, integrin-based cell adhesive responses, and a new HGF binding partner, the nucleolin protein. Here, MET is linked to prostate cancer.